Notice: We have suspended sales of any product not manufactured by one of our third-party partners.  We are suspending sales of products that are manufactured in-house at our facility in Portland, OR for the time being. This suspension will affect a total of 36 SKUs-- including our Finishing Spices, Day Shots, Night Shots, and CBD-infused Sauces-- and will be effective immediately. The affected products have already been removed from our site at the time this notice was published. We are still offering a wide variety of CBD infused products and the vast majority of our customers will be unaffected. We apologize for any inconvenience this may cause and we will work as quickly as possible to make sure we can bring the affected products back to market. If you have any questions or concerns, please contact us at info@cbdkindofday.com or by phone at 971-229-0074

A new study from Richard B. van Breemen at Oregon State University Department of Pharmaceutical Sciences, and co-authors from the Oregon Health & Science University Department of Microbiology & Immunology has been published in the American Chemical Society Journal of Natural Products, and shows that some cannabinoids found in hemp-- the male cannabis plant-- can help block the SARS-CoV-2 virus from binding to the ACE2 receptor and infecting a host. The specific cannabinoids-- CBDA and CBGA-- found in many of our full-spectrum CBD products, was found to increase apelin uptake and bind to the spike protein of the SARS-CoV-2 virus, blocking cellular entry of the virus into the host. From the study abstract: As a complement to vaccines, small-molecule therapeutic agents are needed to treat or prevent infections by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants, which cause COVID-19. Affinity selection−mass spectrometry was used for the discovery of botanical ligands to the SARS-CoV-2 spike protein. Cannabinoid...